Stay updated on PK and Safety in Pregnant Women With HIV: Clinical Trial
Sign up to get notified when there's something new on the PK and Safety in Pregnant Women With HIV: Clinical Trial page.

Latest updates to the PK and Safety in Pregnant Women With HIV: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of collaborators, specifically GlaxoSmithKline. Significant content regarding a study on the dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) treatment for pregnant women has been removed.SummaryDifference17%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to PK and Safety in Pregnant Women With HIV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety in Pregnant Women With HIV: Clinical Trial page.